This is partly due to the fact that global ablation of CaV2.1 channels by Cacna1a gene deletion in a gene targeting knock-out strategy produces mutant mice with progressive neurological deficits that result in ataxia and dystonia, and that limits survival 3 to 4 weeks after birth [11]–[13]. The gene discussed is CACNA1A; the disease is Dystonia.